Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population

被引：0

作者：

Pillinger, Michael ^{[1
]}

Samuels, Svetlana Krasnokutsky ^{[1
]}

Malamet, Raymond ^{[2
]}

Schechter, Bruce ^{[2
]}

Taylor, Douglas C. A. ^{[3
]}

Morlock, Robert ^{[4
]}

机构：

[1] NYU, New York, NY USA

[2] AstraZeneca, Gaithersburg, MD USA

[3] Ironwood Pharmaceut, Cambridge, MA USA

[4] Ardea Biosci Inc, San Diego, CA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

229

引用

页数：2

共 50 条

[31] Association of real-world wearable mobility measures with Parkinson's disease severity and disease progression
Mirelman, A.
Volkov, J.
Solomon, A.
Gazit, E.
Nieuwboer, A.
Del Din, S.
Rochester, L.
Avanzino, L.
Pelosin, E.
Bloem, B.
Della Croce, U.
Cereatti, A.
Thaler, A.
Shirvan, J.
Cedarbaum, J.
Giladi, N.
Hausdorff, J.
MOVEMENT DISORDERS, 2023, 38 : S786 - S786
[32] Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare
Guckenberger, M.
Ricardi, U.
Scorsetti, M.
Balermpas, P.
Lievens, Y.
Alongi, F.
Livi, L.
Braam, P.
Jereczek-Fossa, B. A.
Stellamans, K.
Verbeke, L.
Peulen, H.
Khanfir, K.
Ramella, S.
Zilli, T.
Geets, X.
Hemmatazad, H.
Ivaldi, G. B.
Ratosa, I.
Jeene, P.
Fournier, B.
Fortpied, C.
Ost, P.
RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S568 - S569
[33] The efficacy and toxicity of immune checkpoint inhibitors in a real-world older patient population
Sattar, Joobin
Kartolo, Adi
Hopman, Wilma M.
Lakoff, Joshua Matthew
Baetz, Tara
JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (03) : 411 - 414
[34] PATIENT CHARACTERISTICS AND DISEASE BURDEN OF PSORIASIS IN MEXICO: A REAL-WORLD PHYSICIAN AND PATIENT SURVEY
Barbeau, M.
Romo, X.
Guevara-Sangines, E.
Pietri, G.
Howe, T.
Gilloteau, I
Tian, H.
MacPherson, A.
VALUE IN HEALTH, 2017, 20 (09) : A808 - A808
[35] Venous Thromboembolism in Patients With Myeloma: Incidence and Risk Factors in a "Real-World" Population
Crowley, Maeve P.
Eustace, Joseph A.
O'Shea, Susan I.
Gilligan, Oonagh M.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 600 - 606
[36] The availability of laboratory data in real-world data and association of temporal and patient factors
Dillon, Paul
Arnold, Phil
Chaudhary, Nayan
Flahavan, Evelyn M.
Meyer, Anne-Marie
Davies, Jessica
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 324 - 325
[37] MEASURING PSORIASIS DISEASE ACTIVITY IN THE REAL-WORLD SETTING: RELATIONSHIP BETWEEN THE PHYSICIAN GLOBAL ASSESSMENT AND BODY SURFACE AREA PRODUCT AND THE PSORIASIS AREA AND SEVERITY INDEX
Althoff, A.
Rasouliyan, L.
Kumar, V
Chang, S.
Long, S.
VALUE IN HEALTH, 2023, 26 (06) : S240 - S240
[38] Validity and Reliability of the Fatigue Severity Scale in a Real-World Interstitial Lung Disease Cohort
Aronson, Kerri I.
Martin-Schwarze, Adam M.
Swigris, Jeffrey J.
Kolenic, Giselle
Krishnan, Jamuna K.
Podolanczuk, Anna J.
Kaner, Robert J.
Martinez, Fernando J.
Safford, Monika M.
Pinheiro, Laura C.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 208 (02) : 188 - 195
[39] Severity and burden of sickle cell disease (SCD) in France: A nationwide real-world study
Brousse, Valentine
Bernaudin, Francoise
Dheyriat, Lucile
Chillotti, Louis
Goguillot, Melanie
Gallagher, Meghan
Bugnard, Francoise
Benard, Steve
Habibi, Anoosha
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 415 - 416
[40] Assessing the change in disease severity based on depressive symptoms in real-world psoriasis patients
Shahriari, Neda
Mattessich, Sarah
Lin, Tin-Chi
Litman, Heather J.
McLean, Robert R.
Dube, Blessing
Shahriari, Mona
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (16) : 1215 - 1224

← 1 2 3 4 5 →